Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for Alexithymia in People Living with HIV
NCT05832281Phase 2Terminated
- Sponsor
- University of California, San Diego
- Start
- Mar 2024
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alexithymia (2 arms), sponsored by University of California, San Diego. Primary endpoint: Toronto Alexithymia Scale-20 Item Version at 4 weeks. Started Mar 2024; status: terminated.
02
Conditions
alexithymia
Beyond the preview
Go deeper on NCT05832281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05832281.